At the news
? NEUTRALIMPACT 3/10 SC 13G filed Nov 10, 2026 at 09:24 ET
State Street Corporation filed a Schedule 13G disclosing passive beneficial ownership of 3,017,072 shares of Twist Bioscience Corp, representing 4.6% of shares outstanding as of September 30, 2026. This is a new 5%+ disclosure by State Street, though the stake is just below the 5% threshold at 4.6%, indicating a routine passive position by a large custodian bank.
- State Street Corp filed a Schedule 13G on November 10, 2026, reporting beneficial ownership of 3,017,072 shares of Twist Bioscience Corp common stock.
- The stake represents 4.6% of shares outstanding as of September 30, 2026.
- State Street certifies the shares were acquired and held in the ordinary course of business, with no intent to change or influence control of the issuer.
- The filing is a new 13G disclosure by State Street; prior filings by FMR LLC (Fidelity) and ARK Investment Management were also passive stakes.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access